EW vs. GKOS: Edwards Lifesciences vs. Glaukos Stock Comparison
How do Edwards Lifesciences (EW) and Glaukos (GKOS) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Edwards Lifesciences (EW) and Glaukos (GKOS) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | EW | GKOS |
|---|---|---|
| Name | Edwards Lifesciences Corporation | Glaukos Corp. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 58.73 billion USD | 13.28 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | March 27, 2000 | June 25, 2015 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | EW | GKOS |
|---|---|---|
| Total Return (1Y) | 25.08% | 179.91% |
| Total Return (3Y, Annualized) | 17.28% | 55.51% |
| Total Return (5Y, Annualized) | -2.77% | 35.14% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | EW | GKOS |
|---|---|---|
| Volatility (1Y, Annualized) | 25.58% | 61.24% |
| Beta (5Y) | 0.78 | 0.68 |
| Max Drawdown (5Y) | -54.32% | -53.68% |
| Avg. Volume (3M) | 3.69M | 1.15M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | EW | GKOS |
|---|---|---|
| Sharpe Ratio (1Y) | 0.81 | 2.87 |
| Sortino Ratio (1Y) | 1.23 | 5.93 |
Profitability
ROE (TTM)
Glaukos (GKOS) reports a negative ROE of -22.84%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Edwards Lifesciences (EW) reports 9.33%, ranking against industry peers normally.
EW
Health Care Equipment & Services industry group
9.33%
- Max
- 47.61%
- Q3
- 14.36%
- EW
- 9.33%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
GKOS
Health Care Equipment & Services industry group
-22.84%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- GKOS
- -22.84%
- Min
- -47.01%
Net Margin (TTM)
Glaukos (GKOS) reports a negative net margin of -24.60%, usually indicating a net loss over the period. Meanwhile Edwards Lifesciences (EW) reports 15.30%, ranking against industry peers normally.
EW
Health Care Equipment & Services industry group
15.30%
- Max
- 29.35%
- EW
- 15.30%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
GKOS
Health Care Equipment & Services industry group
-24.60%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- GKOS
- -24.60%
- Min
- -28.46%
Operating Margin (TTM)
Edwards Lifesciences (EW) at 30.15% operates in the top operating margin quartile, ahead of Glaukos (GKOS) at 0.39%, which runs around its industry’s norm.
EW
Health Care Equipment & Services industry group
30.15%
- Max
- 35.43%
- EW
- 30.15%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
GKOS
Health Care Equipment & Services industry group
0.39%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- GKOS
- 0.39%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | EW | GKOS |
|---|---|---|
| ROE (TTM) | 9.33% | -22.84% |
| ROA (TTM) | 8.77% | -3.90% |
| Net Margin (TTM) | 15.30% | -24.60% |
| Operating Margin (TTM) | 30.15% | 0.39% |
| Gross Margin (TTM) | 78.02% | 81.13% |
Growth
Revenue Growth
Glaukos (GKOS) at 32.33% sits in the top revenue growth quartile, while Edwards Lifesciences (EW) at 11.55% is closer to the peer norm — faster top-line expansion for GKOS.
EPS Growth
Only one side can be read here: Edwards Lifesciences (EW) reports EPS growth of -73.74%, ranked against its industry; Glaukos (GKOS) has no EPS growth figure this period.
Growth Metrics
| Metric | EW | GKOS |
|---|---|---|
| Revenue Growth (YoY) | 11.55% | 32.33% |
| Revenue Growth (3Y CAGR) | 10.77% | 21.51% |
| EPS Growth (YoY) | -73.74% | -- |
| EPS Growth (3Y CAGR) | -9.14% | -- |
Financial Strength
Current Ratio (MRQ)
Both Edwards Lifesciences (EW) at 4.60 and Glaukos (GKOS) at 4.57 post current ratio above their industries’ typical mid-ranges — short-term liquidity appears comfortable, though unusually high readings can point to idle current assets.
EW
Health Care Equipment & Services industry group
4.60
- Max
- 7.59
- EW
- 4.60
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
GKOS
Health Care Equipment & Services industry group
4.57
- Max
- 7.59
- GKOS
- 4.57
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Edwards Lifesciences (EW) at 0.06 and Glaukos (GKOS) at 0.15 keep leverage in the lower quartile of their industries, with less balance-sheet debt relative to equity than most peers.
EW
Health Care Equipment & Services industry group
0.06
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- EW
- 0.06
- Min
- 0.00
GKOS
Health Care Equipment & Services industry group
0.15
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- GKOS
- 0.15
- Min
- 0.00
Financial Strength Metrics
| Metric | EW | GKOS |
|---|---|---|
| Current Ratio (MRQ) | 4.60 | 4.57 |
| Debt / Equity (MRQ) | 0.06 | 0.15 |
| Net Debt / EBITDA | -1.88 | -- |
Dividends
Dividend Yield (TTM)
Neither Edwards Lifesciences (EW) nor Glaukos (GKOS) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
GKOS
Health Care Equipment & Services industry group
0.00%
- GKOS
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Edwards Lifesciences (EW) nor Glaukos (GKOS) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
GKOS
Health Care Equipment & Services industry group
0.00%
- GKOS
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | EW | GKOS |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: Edwards Lifesciences (EW) trades at 59.38 times trailing earnings, ranked against its peers, while Glaukos (GKOS) has no P/E ratio this period.
EW
Health Care Equipment & Services industry group
59.38
- Max
- 80.41
- EW
- 59.38
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
GKOS
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- GKOS
- --
P/S Ratio (TTM)
Both look expensive on sales: Edwards Lifesciences (EW) at 8.80 sits in the upper P/S ratio quartile, and Glaukos (GKOS) at 19.24 prices even higher, above its industry range.
EW
Health Care Equipment & Services industry group
8.80
- EW
- 8.80
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
GKOS
Health Care Equipment & Services industry group
19.24
- GKOS
- 19.24
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Edwards Lifesciences (EW) at 5.41 sits near its industry’s typical P/B ratio, while Glaukos (GKOS) at 18.51 prices above its benchmark range — GKOS looks rich relative to book.
EW
Health Care Equipment & Services industry group
5.41
- Max
- 11.68
- Q3
- 6.12
- EW
- 5.41
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
GKOS
Health Care Equipment & Services industry group
18.51
- GKOS
- 18.51
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | EW | GKOS |
|---|---|---|
| P/E Ratio (TTM) | 59.38 | -- |
| P/S Ratio (TTM) | 8.80 | 19.24 |
| P/B Ratio (MRQ) | 5.41 | 18.51 |
| Free Cash Flow Yield (TTM) | 1.95% | 0.40% |